title: Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.
abstract: The treatment of schizophrenia changed drastically with the discovery of antipsychotic medications in the 1950s, the release of clozapine in the US in 1989 and the subsequent development of the atypical or novel antipsychotics. These newer medications differ from their conventional counterparts, primarily based on their reduced risk of extrapyramidal symptoms (EPS). EPS can be categorised as acute (dystonia, akathisia and parkinsonism) and tardive (tardive dyskinesia and tardive dystonia) syndromes. They are thought to have a significant impact on subjective tolerability and adherence with antipsychotic therapy in addition to impacting function. Unlike conventional antipsychotic medications, atypical antipsychotics have a significantly diminished risk of inducing acute EPS at recommended dose ranges. These drugs may also have a reduced risk of causing tardive dyskinesia and in some cases may have the ability to suppress pre-existing tardive dyskinesia. This paper reviews the available evidence regarding the incidence of acute EPS and tardive syndromes with atypical antipsychotic therapy. Estimates of incidence are subject to several confounds, including differing methods for detection and diagnosis of EPS, pretreatment effects and issues surrounding the administration of antipsychotic medications. The treatment of acute EPS and tardive dyskinesia now includes atypical antipsychotic therapy itself, although other adjunctive strategies such as antioxidants have also shown promise in preliminary trials. The use of atypical antipsychotics as first line therapy for the treatment of schizophrenia is based largely on their reduced risk of EPS compared with conventional antipsychotics. Nevertheless, EPS with these drugs can occur, particularly when prescribed at high doses. The EPS advantages offered by the atypical antipsychotics must be balanced against other important adverse effects, such as weight gain and diabetes mellitus, now known to be associated with these drugs.
authors.affiliation: David Geffen School of Medicine at UCLA, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA. joseph.pierre2@med.va.gov
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Pierre
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*; D006801:Humans
chemical_list: D014150:Antipsychotic Agents
references.citation: Arch Gen Psychiatry. 1988 Jan;45(1):79-91
references.pmid: 2892478
references.citation: Drug Saf. 2000 Jan;22(1):73-81
references.pmid: 10647977
references.citation: Ann Pharmacother. 2000 Dec;34(12):1487-8
references.pmid: 11144710
references.citation: J Clin Psychopharmacol. 1987 Aug;7(4):243-6
references.pmid: 3624506
references.citation: Am J Psychiatry. 2000 Jul;157(7):1150-5
references.pmid: 10873925
references.citation: Psychiatr Prax. 2002 Sep;29(6):315-7
references.pmid: 12224042
references.citation: J Clin Psychiatry. 1989 Apr;50(4):132-5
references.pmid: 2925601
references.citation: Int J Neuropsychopharmacol. 1999 Dec;2(4):333-334
references.pmid: 11285150
references.citation: Int Clin Psychopharmacol. 2002 Sep;17(5):263-4
references.pmid: 12177588
references.citation: Cochrane Database Syst Rev. 2000;(2):CD000209
references.pmid: 10796508
references.citation: Br J Psychiatry. 1999 Jan;174:23-30
references.pmid: 10211147
references.citation: Int Clin Psychopharmacol. 2001 Nov;16(6):369-71
references.pmid: 11712627
references.citation: J Clin Psychiatry. 1996 Apr;57(4):167-73
references.pmid: 8601552
references.citation: Psychopharmacol Bull. 1995;31(2):259-64
references.pmid: 7491377
references.citation: Am J Psychiatry. 2004 Mar;161(3):414-25
references.pmid: 14992963
references.citation: Arch Gen Psychiatry. 1988 Sep;45(9):789-96
references.pmid: 3046553
references.citation: J Clin Psychopharmacol. 1999 Jun;19(3):276-7
references.pmid: 10350038
references.citation: Am J Psychiatry. 1999 Jul;156(7):990-9
references.pmid: 10401441
references.citation: J Clin Psychiatry. 1996 Oct;57(10):449-54
references.pmid: 8909330
references.citation: Schizophr Bull. 2002;28(1):31-42
references.pmid: 12047020
references.citation: Schizophr Bull. 1997;23(4):583-609
references.pmid: 9365997
references.citation: J Clin Psychopharmacol. 1997 Aug;17(4):308-13
references.pmid: 9241011
references.citation: Eur Psychiatry. 2003 Aug;18(5):260-1
references.pmid: 12927329
references.citation: Am J Psychiatry. 2002 Aug;159(8):1436
references.pmid: 12153846
references.citation: Ann Clin Psychiatry. 1998 Sep;10(3):101-5
references.pmid: 9781472
references.citation: J Clin Psychiatry. 1999 Nov;60(11):771-5
references.pmid: 10584767
references.citation: J Clin Psychopharmacol. 1999 Feb;19(1):100-1
references.pmid: 9934952
references.citation: Arch Gen Psychiatry. 1991 Aug;48(8):739-45
references.pmid: 1883257
references.citation: Schizophr Res. 1999 Aug 23;39(1):1-16; discussion 17-8
references.pmid: 10480663
references.citation: Arch Neurol. 2002 Jul;59(7):1125-32
references.pmid: 12117360
references.citation: Ann Intern Med. 1999 Jul 6;131(1):72
references.pmid: 10391826
references.citation: Pharmacopsychiatry. 1998 Mar;31(2):68-9
references.pmid: 9562211
references.citation: J Clin Psychiatry. 1999 May;60(5):340-1
references.pmid: 10362448
references.citation: J Clin Psychopharmacol. 1998 Aug;18(4):296-304
references.pmid: 9690695
references.citation: Am J Psychiatry. 2001 Mar;158(3):360-9
references.pmid: 11229973
references.citation: J Clin Psychopharmacol. 1987 Dec;7(6):377-84
references.pmid: 3323261
references.citation: Mov Disord. 1999 Jul;14(4):652-7
references.pmid: 10435503
references.citation: Biol Psychiatry. 1998 Jun 15;43(12):868-72
references.pmid: 9627740
references.citation: Schizophr Res. 2001 Mar 1;47(2-3):309-10
references.pmid: 11322143
references.citation: Schizophr Bull. 1988;14(2):291-6
references.pmid: 2904696
references.citation: Neurology. 1982 May;32(5):558-9
references.pmid: 6122190
references.citation: J Clin Psychopharmacol. 1997 Jun;17(3):194-201
references.pmid: 9169965
references.citation: Schizophr Bull. 2002;28(1):17-29
references.pmid: 12047017
references.citation: Am J Psychiatry. 1999 May;156(5):796-7
references.pmid: 10327920
references.citation: Am J Psychiatry. 1997 Sep;154(9):1248-54
references.pmid: 9286184
references.citation: Eur Psychiatry. 2000 Nov;15(7):438-9
references.pmid: 11112937
references.citation: Biol Psychiatry. 1993 May 15;33(10):700-6
references.pmid: 8102552
references.citation: Arch Gen Psychiatry. 1997 Jun;54(6):549-57
references.pmid: 9193196
references.citation: Br J Psychiatry. 1989 May;154:672-6
references.pmid: 2574607
references.citation: J Clin Psychopharmacol. 1995 Feb;15(1 Suppl 1):36S-44S
references.pmid: 7537286
references.citation: Biol Psychiatry. 1999 Mar 15;45(6):715-30
references.pmid: 10188001
references.citation: J Clin Psychopharmacol. 1989 Dec;9(6):407-11
references.pmid: 2574192
references.citation: Clin Ther. 2001 Nov;23(11):1839-54
references.pmid: 11768836
references.citation: J Clin Psychiatry. 1997 Jul;58(7):318-22
references.pmid: 9269253
references.citation: J Clin Psychiatry. 1999;60 Suppl 12:22-3
references.pmid: 10372606
references.citation: Ann Clin Psychiatry. 1996 Mar;8(1):27-9
references.pmid: 8743646
references.citation: Am J Psychiatry. 1994 Jun;151(6):825-35
references.pmid: 7514366
references.citation: Arch Gen Psychiatry. 1999 Sep;56(9):836-41
references.pmid: 12892048
references.citation: J Clin Psychiatry. 1999 Dec;60(12 ):870
references.pmid: 10665640
references.citation: J Clin Psychopharmacol. 1995 Feb;15(1 Suppl 1):45S-51S
references.pmid: 7537287
references.citation: J Pharmacol Exp Ther. 1992 Aug;262(2):699-706
references.pmid: 1380082
references.citation: Arch Gen Psychiatry. 1982 Jul;39(7):803-16
references.pmid: 6131655
references.citation: Int Clin Psychopharmacol. 2000 Jan;15(1):57-60
references.pmid: 10836289
references.citation: Neuropsychopharmacology. 1999 May;20(5):491-505
references.pmid: 10192829
references.citation: J Clin Psychiatry. 1998 Jan;59(1):29-30
references.pmid: 9491064
references.citation: Can J Psychiatry. 1990 Oct;35(7):576-80
references.pmid: 1980092
references.citation: Am J Psychiatry. 1992 Mar;149(3):391-3
references.pmid: 1346951
references.citation: J Clin Psychiatry. 1993 Sep;54(9):327-30
references.pmid: 8104929
references.citation: Eur Psychiatry. 2000 Aug;15(5):338-9
references.pmid: 10954879
references.citation: Eur Psychiatry. 2002 Nov;17 (7):421-4
references.pmid: 12547311
references.citation: Eur Neuropsychopharmacol. 1999 Jun;9(4):367-8
references.pmid: 10422899
references.citation: Am J Psychiatry. 2001 Oct;158(10):1737
references.pmid: 11579018
references.citation: Ann Pharmacother. 2001 Dec;35(12 ):1517-22
references.pmid: 11793611
references.citation: J Clin Psychiatry. 2001 Apr;62(4):298-9
references.pmid: 11379849
references.citation: J Clin Psychiatry. 1987 Jul;48(7):263-7
references.pmid: 2885310
references.citation: Acta Psychiatr Scand. 1999 Mar;99(3):160-70
references.pmid: 10100910
references.citation: Schizophr Res. 2003 Jun 1;61(2-3):123-36
references.pmid: 12729864
references.citation: Psychopharmacology (Berl). 1978 Jan 31;56(1):75-80
references.pmid: 415329
references.citation: J Clin Psychopharmacol. 1997 Oct;17 (5):407-18
references.pmid: 9315992
references.citation: J Clin Psychiatry. 2000;61 Suppl 4:45-57
references.pmid: 10739331
references.citation: Schizophr Res. 2000 Dec 15;46(2-3):107-9
references.pmid: 11120422
references.citation: Arch Gen Psychiatry. 2001 Nov;58(11):1049-52
references.pmid: 11695951
references.citation: N Engl J Med. 2002 Jan 3;346(1):16-22
references.pmid: 11777998
references.citation: Am J Psychiatry. 1992 Jun;149(6):773-7
references.pmid: 1350428
references.citation: Psychiatr Clin North Am. 2003 Mar;26(1):165-90
references.pmid: 12683265
references.citation: J Nerv Ment Dis. 1985 Jun;173(6):353-7
references.pmid: 3998720
references.citation: Am J Psychiatry. 1993 Sep;150(9):1405-7
references.pmid: 8102511
references.citation: Aust N Z J Psychiatry. 2000 Jun;34(3):355-69
references.pmid: 10881961
references.citation: Pharmacopsychiatry. 2000 Jul;33(4):155-6
references.pmid: 10958268
references.citation: J Am Geriatr Soc. 1999 Jun;47(6):716-9
references.pmid: 10366172
references.citation: J Clin Psychopharmacol. 1993 Feb;13(1):25-40
references.pmid: 7683702
references.citation: J Med Assoc Thai. 2000 Nov;83(11):1430-2
references.pmid: 11215878
references.citation: Cochrane Database Syst Rev. 2001;(4):CD000209
references.pmid: 11687073
references.citation: J Clin Psychopharmacol. 2001 Aug;21(4):375-81
references.pmid: 11476121
references.citation: Arch Gen Psychiatry. 2000 Jun;57(6):553-9
references.pmid: 10839333
references.citation: Br J Psychiatry. 1999 Oct;175:391-2
references.pmid: 10789313
references.citation: Arch Gen Psychiatry. 1990 Aug;47(8):754-8
references.pmid: 2378546
references.citation: Clin Neuropharmacol. 2002 Mar-Apr;25(2):71-4
references.pmid: 11981231
references.citation: Clin Neuropharmacol. 1998 Jan-Feb;21(1):68-9
references.pmid: 9579290
references.citation: J Clin Psychiatry. 2000;61 Suppl 4:39-44
references.pmid: 10739330
references.citation: Acta Psychiatr Scand Suppl. 1994;382:11-5
references.pmid: 7916523
references.citation: Am J Psychiatry. 1990 Apr;147(4):505-6
references.pmid: 1969247
references.citation: J Clin Psychiatry. 1995 Oct;56(10):484-5
references.pmid: 7559377
references.citation: J Clin Psychiatry. 2002 Sep;63(9):763-71
references.pmid: 12363115
references.citation: Biol Psychiatry. 1994 Jun 1;35(11):886-7
references.pmid: 8054412
references.citation: Schizophr Bull. 1999;25(4):741-8
references.pmid: 10667744
references.citation: Psychopharmacology (Berl). 1998 Nov;140(2):173-84
references.pmid: 9860108
references.citation: Schizophr Bull. 1997;23(4):663-74
references.pmid: 9366002
references.citation: J Clin Psychiatry. 1998 Jul;59(7):380-1
references.pmid: 9714267
references.citation: Eur Arch Psychiatry Clin Neurosci. 1998;248(4):209-11
references.pmid: 9810484
references.citation: Psychopharmacology (Berl). 2000 Jan;148(1):3-15
references.pmid: 10663410
references.citation: JAMA. 1961 Mar 25;175:1054-60
references.pmid: 13685365
references.citation: J Postgrad Med. 1993 Jul-Sep;39(3):124-6
references.pmid: 7914238
references.citation: Am J Psychiatry. 1996 May;153(5):734-5
references.pmid: 8615429
references.citation: J Nerv Ment Dis. 1994 Feb;182(2):113-4
references.pmid: 8308529
references.citation: Can J Psychiatry. 1999 Jun;44(5):507-8
references.pmid: 10389620
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 1996 Feb;20(2):263-74
references.pmid: 8861192
references.citation: J Clin Psychiatry. 2002 Feb;63(2):167-8
references.pmid: 11874222
references.citation: J Clin Psychiatry. 2002 Jun;63(6):516-23
references.pmid: 12088164
references.citation: Am J Psychiatry. 1999 Dec;156(12 ):2016
references.pmid: 10588425
references.citation: Harv Rev Psychiatry. 2002 Sep-Oct;10(5):280-91
references.pmid: 12202454
references.citation: Biol Psychiatry. 1997 Aug 15;42(4):233-46
references.pmid: 9270900
references.citation: J Clin Psychiatry. 1998 Sep;59(9):472-7
references.pmid: 9771818
references.citation: J Clin Psychiatry. 1997 May;58(5):205-11
references.pmid: 9184614
references.citation: Arch Gen Psychiatry. 1982 Apr;39(4):486-7
references.pmid: 6121550
references.citation: Lancet. 2003 May 10;361(9369):1581-9
references.pmid: 12747876
references.citation: Am J Psychiatry. 2001 May;158(5):765-74
references.pmid: 11329400
references.citation: Br J Psychiatry. 1991 Apr;158:503-10
references.pmid: 1675900
references.citation: Am J Psychiatry. 1999 Aug;156(8):1290
references.pmid: 10450277
references.citation: J Clin Psychiatry. 1994 Sep;55 Suppl B:102-6
references.pmid: 7961550
references.citation: Am J Psychiatry. 1996 Jun;153(6):843
references.pmid: 8633711
references.citation: J Pharmacol Exp Ther. 1989 Oct;251(1):238-46
references.pmid: 2571717
references.citation: Schizophr Res. 1999 Mar 1;35 Suppl:S61-6
references.pmid: 10190226
references.citation: Schizophr Bull. 1999;25(4):731-40
references.pmid: 10667743
references.citation: Schizophr Res. 1997 Dec 19;28(2-3):231-46
references.pmid: 9468357
references.citation: Am J Psychiatry. 1994 Jun;151(6):925-6
references.pmid: 8185007
references.citation: Arch Gen Psychiatry. 1993 Sep;50(9):723-33
references.pmid: 8102845
references.citation: J Am Acad Child Adolesc Psychiatry. 1996 Nov;35(11):1421-2
references.pmid: 8936904
references.citation: J Psychosoc Nurs Ment Health Serv. 1993 Sep;31(9):14-8
references.pmid: 7901407
references.citation: Psychopharmacology (Berl). 1982;77(2):105-8
references.pmid: 6812127
references.citation: Biol Psychiatry. 1999 Jun 15;45(12):1630-5
references.pmid: 10376125
references.citation: Arch Gen Psychiatry. 1998 Mar;55(3):279-80
references.pmid: 9510225
references.citation: Acta Psychiatr Scand Suppl. 1970;212:11-9
references.pmid: 4917967
references.citation: J Clin Psychiatry. 2001;62 Suppl 21:15-8
references.pmid: 11584982
references.citation: S D J Med. 2000 Feb;53(2):65-7
references.pmid: 10731859
references.citation: Eur Psychiatry. 1999 Jul;14(4):245-7
references.pmid: 10572353
references.citation: Biol Psychiatry. 1997 Jan 1;41(1):114-6
references.pmid: 8988802
references.citation: Med Health R I. 1998 Aug;81(8):271-2
references.pmid: 9727307
references.citation: Int Clin Psychopharmacol. 1998 Jul;13(4):147-55
references.pmid: 9727725
references.citation: Schizophr Res. 1999 Jan 4;35(1):51-68
references.pmid: 9988841
references.citation: Neurol Sci. 2001 Aug;22(4):331-2
references.pmid: 11808858
references.citation: Can J Psychiatry. 2000 Mar;45(2):202
references.pmid: 10742889
references.citation: Br J Psychiatry. 1995 Jun;166(6):712-26; discussion 727-33
references.pmid: 7545060
references.citation: Am J Psychiatry. 2003 Mar;160(3):588
references.pmid: 12611849
references.citation: J Clin Psychiatry. 1999;60 Suppl 10:15-9
references.pmid: 10340683
references.citation: BMJ. 2000 Dec 2;321(7273):1371-6
references.pmid: 11099280